Home/Filings/4/0001104659-22-001643
4//SEC Filing

McGroarty Jeffrey Brian 4

Accession 0001104659-22-001643

CIK 0001477845other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 7:43 PM ET

Size

5.5 KB

Accession

0001104659-22-001643

Insider Transaction Report

Form 4
Period: 2022-01-03
McGroarty Jeffrey B
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2022-01-03+28,00028,000 total
    Exercise: $19.78Exp: 2032-01-03Common Stock (28,000 underlying)
Footnotes (1)
  • [F1]The stock option shall vest in eight consecutive quarterly installments of 3,500 shares each on the 3rd day of April, July, October and January of each year, commencing April 3, 2022, and continuing through January 3, 2024.

Issuer

Annovis Bio, Inc.

CIK 0001477845

Entity typeother

Related Parties

1
  • filerCIK 0001563273

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 7:43 PM ET
Size
5.5 KB